Patients with severe COVID-19 should be tested for hyperinflammation, caused by an overactive immune response to the virus, and clinical trials are needed to determine if immunosuppressants can help reduce deaths, says Dr Puja Mehta (UCL Medicine).
Read: i News
Close
